Skip to main content

Day: November 15, 2023

BioSyent Declares Fourth Quarter 2023 Dividend

MISSISSAUGA, Ontario, Nov. 15, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in Canadian Dollars on December 15, 2023, to shareholders of record at the close of business on November 30, 2023. This fourth quarter 2023 dividend compares with the third quarter 2023 dividend of $0.04 per common share. This dividend qualifies as an ‘eligible dividend’ for Canadian income tax purposes. The declaration, timing, amount and payment of future dividends remain at the discretion of the Board of Directors. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on...

Continue reading

MEGA MATRIX CORP. announced that it has entered into a Non-binding Letter of Intent with Yuder Pte, Ltd, a Mid-Length Streaming Platform Company focusing on Short Drama

PALO ALTO, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced that it has entered into a non-binding letter of intent to acquire sixty percent (60%) of the voting capital stock (the “Acquisition”) of Yuder Pte, Ltd. (“Yuder”), a mid-length streaming platform company focusing on short drama in exchange for 1,500,000 shares of the Company’s common stock, par value $0.001. The completion of the proposed Acquisition is subject to, among other things, the completion of due diligence, the negotiation of definitive agreements for the Acquisition (the “Definitive Agreements”), satisfaction of the conditions negotiated therein, approval of the transaction by the board and stockholders of both the Company and Yuder, as well as regulatory approvals...

Continue reading

J&J Snack Foods’ Fiscal 2023 Fourth Quarter Revenue Increases 10.8% to a Quarterly Record of $443.9M

-Full Year Fiscal 2023 Revenue Grows 12.9%- MOUNT LAUREL, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) — J&J Snack Foods Corp. (NASDAQ: JJSF) (the “Company”) today reported financial results for the fourth quarter and full year ended September 30, 2023.  Fourth Quarter Full-YearActuals % v. LY Actuals % v. LYNet Sales $443.9M 10.8% $1,558.8M 12.9%Operating Income $41.7M 93.0% $109.5M 77.2%Net Earnings $30.4M 75.7% $78.9M 67.1%Earnings per Diluted Share $1.57 74.4% $4.08 65.9%         Adjusted EBITDA $62.2M 55.2% $181.6M 46.3%Adjusted Earnings per Diluted Share $1.73 64.8% $4.50 63.0%This press release contains non-GAAP financial measures. Please refer to the Non-GAAP Financial Measures section below for reconciliations to the most comparable GAAP measures. Dan Fachner, J&J Snack Foods President...

Continue reading

JOANN Schedules Third Quarter Fiscal 2024 Earnings Release and Conference Call

HUDSON, Ohio, Nov. 15, 2023 (GLOBE NEWSWIRE) — JOANN Inc. (NASDAQ: JOAN) (“JOANN”), the nation’s category leader in sewing and fabrics with one of the largest arts and crafts offerings, today announced plans to release its earnings for the third quarter Fiscal 2024 after the market closes on Monday, December 4, 2023. JOANN will host a conference call on the same day at 5:00 p.m. ET. The toll-free number to call for the live interactive teleconference is: 1 (844) 481-2750 and international dial in number is: 1 (412) 317-0666. Participants should ask to be joined into the JOANN call. The live broadcast of JOANN’s conference call will be available online at investors.joann.com. The online replay will follow shortly after the call and will be available for one year. During the conference call, the Company may discuss and answer questions...

Continue reading

StoneX Group Inc. Reports Fiscal 2023 Fourth Quarter Financial Results

Record Fiscal Year Results in 2023, with Diluted EPS of $11.18, up 12% and ROE of 19.5% Quarterly Operating Revenues of $778.0 million, up 33% Quarterly Net Income of $50.7 million, ROE of 15.0% Quarterly Diluted EPS of $2.36 per share NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) — StoneX Group Inc. (the “Company”; NASDAQ: SNEX), a global financial services network that connects companies, organizations, traders and investors to the global market ecosystem through a unique blend of digital platforms, end-to-end clearing and execution services, high touch service and deep expertise, today announced its financial results for the fiscal year 2023 and fourth quarter ended September 30, 2023. Sean M. O’Connor, the Company’s CEO, stated, “We achieved solid results in our fiscal fourth quarter, with pre-tax earnings of $75.4 million, up 14%...

Continue reading

Inari Medical Closes Acquisition of LimFlow

IRVINE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the close of its acquisition of LimFlow S.A., a privately-held pioneer in limb salvage for patients with chronic limb-threatening ischemia (CLTI). “The close of the LimFlow acquisition allows us to begin to integrate this exciting technology that is offering new hope to patients suffering from CLTI,” said Drew Hykes, CEO of Inari. “LimFlow addresses one of the most significant unmet needs in all of vascular medicine, is closely aligned with our mission and adds another highly differentiated growth platform into our portfolio.” On November 1, Inari announced a definitive agreement to acquire LimFlow,...

Continue reading

PennantPark Floating Rate Capital Ltd. Announces Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2023

MIAMI, Nov. 15, 2023 (GLOBE NEWSWIRE) — PennantPark Floating Rate Capital Ltd. (NYSE: PFLT) (TASE: PFLT) announced today financial results for the fourth quarter and fiscal year ended September 30, 2023.HIGHLIGHTS Quarter ended September 30, 2023 (Unaudited) ($ in millions, except per share amounts) Assets and Liabilities:            Investment portfolio(1)         $ 1,067.2  Net assets         $ 653.6  GAAP net asset value per share         $ 11.13  Quarterly increase in GAAP net asset value per share           1.6 %Adjusted net asset value per share(2)         $ 11.13  Quarterly increase in adjusted net asset value per share(2)           1.2 %                          Credit Facility         $ 9.4  2023 Notes         $ 76.2  2026 Notes         $ 183.1  2031 Asset-Backed Debt         $ 226.8  Regulatory...

Continue reading

PennantPark Investment Corporation Announces Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2023

MIAMI, Nov. 15, 2023 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (NYSE: PNNT) announced today financial results for the fourth quarter and fiscal year ended September 30, 2023. HIGHLIGHTS        Year ended September 30, 2023 – Unaudited ($ in millions, except per share amounts)              Assets and Liabilities:          Investment portfolio(1)       $ 1,001.9  Net assets       $ 502.2  Adjusted net asset value per share(2)       $ 7.70  Quarterly increase in adjusted net asset value per share(2)         0.4 %GAAP net asset value per share       $ 7.70  Quarterly decrease in GAAP net asset value per share         (0.3 )%           Credit Facility       $ 206.9  2026 Notes       $ 147.7  2026-2 Notes       $ 162.2  Regulatory Debt to Equity       1.05x  Weighted average yield...

Continue reading

MDB Capital Holdings Reports Third Quarter 2023 Results

Addison, TX, Nov. 15, 2023 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, yesterday reported results for its third quarter ended September 30, 2023 on form 10-Q filed with the Securities and Exchange Commission, and will highlight recent corporate progress on today’s call with management. “The third quarter of 2023 was highlighted by an important milestone in our company’s journey, as we successfully completed our IPO and began trading on the NASDAQ,” said Christopher Marlett, CEO and Co-Founder of MDB. “I look forward to providing an ‘Investor’s Toolkit’ on today’s update call to transparently help shareholders understand how to measure our progress...

Continue reading

PainReform Provides Business Update for the Third Quarter of 2023

Reports enrollment of first patients for the second part of Phase 3 clinical trial in bunionectomy TEL AVIV, Israel, Nov. 15, 2023 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the third quarter ended September 30, 2023. Ilan Hadar, Chief Executive Officer of PainReform, stated, “We are pleased to report a number of recent milestones that have helped advance the clinical development of PRF-110, our lead drug candidate, targeting the post-operative extended pain relief market. Following success in the first part of our Phase 3 clinical trial of PRF-110, we initiated the second, larger part of the Phase 3 trial in bunionectomy....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.